Radionuclide methods for evaluating the results of thrombolytic therapy.
In summary, a variety of nuclear techniques may be used to investigate the effects of thrombolytic therapy and myocardial reperfusion. Assessments of global and regional ventricular function, myocardial perfusion, and metabolic integrity are available and appear to add substantially to conventional assessment. Timing of studies appears to be critical. Complementary data can be obtained in both the acute and convalescent phase of myocardial infarction.
D011756:Diphosphates; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006321:Heart / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009942:Organometallic Compounds; D005082:Physical Exertion; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013667:Technetium; D016698:Technetium Tc 99m Pyrophosphate; D017256:Technetium Tc 99m Sestamibi; D013793:Thallium
D011756:Diphosphates; D005343:Fibrinolytic Agents; D009942:Organometallic Compounds; D011868:Radioisotopes; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; D013793:Thallium